# Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-rituximab-in-moderately-to-severely-active-systemic-lupus/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Joan T. Merrill,C. Michael Neuwelt,Daniel J. Wallace,Joseph C. Shanahan,Kevin Latinis,Jim C. Oates,Tammy O. Utset,Caroline Gordon,David Isenberg,Hsin‐Ju Hsieh,David Zhang,Paul Brunetta |
| Citations | 1,405 |
| DOI | 10.1002/art.27233 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/4548300 |
| OpenAlex ID | https://openalex.org/W2046330020 |
| PMID | 20039413 |
| Type | article |
| Year | 2009 |

## Paper authors

- [Joan T. Merrill](https://scholariq.org/researchers/joan-t-merrill/)
- [Daniel J. Wallace](https://scholariq.org/researchers/daniel-j-wallace/)
- [Caroline Gordon](https://scholariq.org/researchers/caroline-gordon/)
- [David Isenberg](https://scholariq.org/researchers/david-isenberg/)

## Paper primary topic

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Paper topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.